An Atypical Femoral Fracture in a Patient on Long-term Alendronate Therapy. Issue 3 (September 2014)

• Record Type: Journal Article
• Authors: Celbek, Gokhan; Ozsahin, Mustafa; Uslu, Mustafa; Onder, Elif; Kutlucan, Ali; Besir, Fahri Halit; Aydin, Yusuf
• Is Part Of: Journal of musculoskeletal pain. Volume 22:Issue 3(2014)
• Page Start: 322
• Page End: 326
• Publication Date: 2014-09
• Subjects: Nonarticular rheumatism -- Periodicals; Myalgia -- Periodicals; Pain -- Periodicals; Musculoskeletal system -- Diseases -- Periodicals; 616.7
• DOI: 10.3109/10582452.2014.883031
• Languages: English
• ISSNs: 1058-2452

Abstract

<abstract> <title>Abstract</title> <p> <bold>Background</bold>: Biphosphonates, especially alendronate, are used extensively and successfully for the treatment of osteoporosis. However, there are numerous recent studies that indicate low-energy subtrochanteric femoral fractures can be associated with long-term alendronate therapy.</p> <p> <bold>Findings</bold>: We present a 76-year-old female patient who has taken 70 mg alendronate per week for 7 years, and who presented with pain in the left thigh.</p> <p> <bold>Conclusions</bold>: The patient was diagnosed as atypical femoral fracture resulting from long-term alendronate use. The diagnosis and the treatment will be discussed with a review of the literature.</p> </abstract>